Publications

Found 11 results
Filters: Keyword is Cell Line, Tumor  [Clear All Filters]
2016
Zhan, Y-A., R. Abskharon, Y. Li, J. Yuan, L. Zeng, J. Dang, M. Camacho Martinez, Z. Wang, J. Mikol, S. Lehmann, et al., "Quiescin-sulfhydryl oxidase inhibits prion formation .", Aging (Albany NY), vol. 8, issue 12, pp. 3419-3429, 2016 12 11.
Massa, S., N. Vikani, C. Betti, S. Ballet, S. Vanderhaegen, J. Steyaert, B. Descamps, C. Vanhove, A. Bunschoten, F. W. B. van Leeuwen, et al., "Sortase A-mediated site-specific labeling of camelid single-domain antibody-fragments: a versatile strategy for multiple molecular imaging modalities.", Contrast Media Mol Imaging, vol. 11, issue 5, pp. 328-339, 2016 09.
2013
Xavier, C., I. Vaneycken, M. D'huyvetter, J. Heemskerk, M. Keyaerts, C. Vincke, N. Devoogdt, S. Muyldermans, T. Lahoutte, and V. Caveliers, "Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.", J Nucl Med, vol. 54, issue 5, pp. 776-84, 2013 May.
2012
D'huyvetter, M., A. Aerts, C. Xavier, I. Vaneycken, N. Devoogdt, M. Gijs, N. Impens, S. Baatout, B. Ponsard, S. Muyldermans, et al., "Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators.", Contrast Media Mol Imaging, vol. 7, issue 2, pp. 254-64, 2012 Mar-Apr.
Hernot, S., S. Unnikrishnan, Z. Du, T. Shevchenko, B. Cosyns, A. Broisat, J. Toczek, V. Caveliers, S. Muyldermans, T. Lahoutte, et al., "Nanobody-coupled microbubbles as novel molecular tracer.", J Control Release, vol. 158, issue 2, pp. 346-53, 2012 Mar 10.
2011
Roovers, R. C., M. J. W. D. Vosjan, T. Laeremans, R. el Khoulati, R. C. G. de Bruin, K. M. Ferguson, A. J. Verkleij, G. A. M. S. van Dongen, and P. M. P. van Be Henegouwen, "A biparatopic anti-EGFR nanobody efficiently inhibits solid tumour growth.", Int J Cancer, vol. 129, issue 8, pp. 2013-24, 2011 Oct 15.
Gainkam, L. Olive Tcho, M. Keyaerts, V. Caveliers, N. Devoogdt, C. Vanhove, L. Van Grunsven, S. Muyldermans, and T. Lahoutte, "Correlation between epidermal growth factor receptor-specific nanobody uptake and tumor burden: a tool for noninvasive monitoring of tumor response to therapy.", Mol Imaging Biol, vol. 13, issue 5, pp. 940-8, 2011 Oct.
Vaneycken, I., N. Devoogdt, N. Van Gassen, C. Vincke, C. Xavier, U. Wernery, S. Muyldermans, T. Lahoutte, and V. Caveliers, "Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer.", FASEB J, vol. 25, issue 7, pp. 2433-46, 2011 Jul.
Van de Broek, B., N. Devoogdt, A. D'Hollander, H-L. Gijs, K. Jans, L. Lagae, S. Muyldermans, G. Maes, and G. Borghs, "Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy.", ACS Nano, vol. 5, issue 6, pp. 4319-28, 2011 Jun 28.
2010
Vaneycken, I., J. Govaert, C. Vincke, V. Caveliers, T. Lahoutte, P. De Baetselier, G. Raes, A. Bossuyt, S. Muyldermans, and N. Devoogdt, "In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.", J Nucl Med, vol. 51, issue 7, pp. 1099-106, 2010 Jul.
2007
Roovers, R. C., T. Laeremans, L. Huang, S. De Taeye, A. J. Verkleij, H. Revets, H. J. de Haard, and P. M. P. van Be Henegouwen, "Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies.", Cancer Immunol Immunother, vol. 56, issue 3, pp. 303-317, 2007 Mar.